Navigation Links
Quintiles Appoints Christopher Cabell to Chief Medical and Scientific Officer
Date:6/6/2008

RESEARCH TRIANGLE PARK, N.C., June 6 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of Christopher H. Cabell, M.D., MHS, FACC, as Chief Medical and Scientific Officer. Cabell succeeds Oren Cohen, M.D., who was recently appointed Senior Vice President, Clinical Research Strategies.

As Chief Medical and Scientific Officer, Cabell will be responsible for company-wide initiatives that focus on bioethics and the protection of human subjects. In addition, he will be responsible for developing initiatives that bring forward innovations in medicine, science and technology into future business models.

Most recently, Cabell held the position of Global Cardiovascular / Endocrine Therapeutic Group Leader within the Medical and Scientific Services group and provided cardiology expertise for Quintiles Electrocardiogram (ECG) Services. In 2007, Cabell joined Quintiles from the Duke University School of Medicine, where he developed a strong background in clinical research. He held several appointments within the Duke Clinical Research Institute (DCRI), including Co-Chair and Principal Investigator for a Duke/FDA Cardiac Safety partnership to develop a new generation of tools to identify the potential effects of medical devices and drugs on the heart. Also within DCRI, he held appointments as Director of the Echocardiography Core Laboratory, Associate Director of the ECG Core Laboratory and Director of the International Collaboration on Endocarditis. He also was Assistant Professor of Medicine in the Division of Cardiology.

Cabell has authored or co-authored 50 articles for peer-reviewed publications and delivered more than 30 invited lectures. He is a member of several professional organizations, a Fellow of the American College of Cardiology, and a reviewer for a number of medical journals, including the Journal of the American Medical Association. He earned his medical degree and a Master's in Health Science from the Duke University School of Medicine.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, commercialization and strategic partnering for the pharmaceutical, biotechnology and medical device industries. With more than 21,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at http://www.qtrn.com


'/>"/>
SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Expert Cardiologist Joins Quintiles Medical Group
3. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
4. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
5. Quintiles to Open Clinical Research Office in Wilmington, NC
6. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
7. Quintiles Consulting Business Expands
8. Quintiles Signs Agreement to Acquire Eidetics
9. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
10. Codexis Appoints Singapore Laboratories Managing Director
11. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... Having worked on the design of the ... to introduce it to top lab design architects from around the country at the ... of Industrial Design and Engineering Greg Casey will be at the show, where they ...
(Date:4/21/2017)... ... April 21, 2017 , ... Frederick ... a range of emerging bio and technology start-ups, is hosting “Celebration Friday” (a ... double event will start with libations and networking at 3:30 p.m. at FITCI’s ...
(Date:4/20/2017)... Lilly and Company (NYSE: LLY ) will ... of migraine at the American Academy of Neurology (AAN) ... in Boston . ... and patient outcomes data for galcanezumab in patients with ... migraine headache days among patients with episodic migraine. Lilly ...
(Date:4/20/2017)... /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" ... Liver Congress ("ILC") 2017 of the European Association for the ... on the positive effects of PBI-4050 on reduction of ... metabolic syndrome. ... Dr. Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This ...
Breaking Biology Technology:
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):